Healthtech funding in April 2021
European Healthtech startup funding raised during April 2021.
In April 2021, 37 European Healthtech companies closed 37 funding rounds and raised €818M in equity funding (excluding debt and grants), up 55.4% versus April 2020. Sweden led by capital raised, and RA Capital Management was the most active investor. Data as of 20 Nov 2026.
Equity funding
€818M
+55.4% vs April 2020 · excl. debt & grants
Funding rounds
37
-5.1% vs April 2020
Companies
37
Top country
Sweden
Rank among sectors
#5
8.9% of sector funding
Top-10 round share
88.3%
of disclosed capital
Rounds ≥ €100M
1
Top countries
by € raisedHealthtech — top countries by capital, April 2021 — interactive chart.
Data table
| Healthtech — top countries by capital, April 2021 | |
|---|---|
| Sweden | €263M |
| UK | €173M |
| Switzerland | €118M |
| Netherlands | €104M |
| Germany | €62M |
| Israel | €47M |
| Spain | €21M |
| France | €16M |
Stage mix
by € raisedHealthtech — stage mix, April 2021 — interactive chart.
Data table
| Healthtech — stage mix, April 2021 | |
|---|---|
| Series D+ | €324M |
| Other | €200M |
| Series C | €97M |
| Series A | €91M |
| Series B | €85M |
| Seed | €22M |
Exits & M&A
2 Acquisition2 exits.
Top deals
largest disclosed rounds in April 2021| Company | Stage | Date | Amount |
|---|---|---|---|
| Kry | Series D+ | Apr 2021 | €262M |
| CeQur | Series C | Apr 2021 | €97M |
| Lumicks | Other | Apr 2021 | €77M |
| Alchemab Therapeutics | Series A | Apr 2021 | €69M |
| Kaia Health | Series D+ | Apr 2021 | €62M |
| Nucleix | Other | Apr 2021 | €47M |
| Current Health | Series B | Apr 2021 | €36M |
| Proximie | Series B | Apr 2021 | €32M |
| Onward | Other | Apr 2021 | €27M |
| Lion (Spiden) | Other | Apr 2021 | €15M |
| Inbrain Neuroelectronics | Series A | Apr 2021 | €14M |
| Rinri Therapeutics | Other | Apr 2021 | €12M |
| Zedsen | Series B | Apr 2021 | €10M |
| Les Opticiens Mobiles | Series B | Apr 2021 | €7.5M |
| Doctify | Other | Apr 2021 | €6.3M |
Top investors
most active in April 2021, by deal count- RA Capital Management2 deals
- 3VC1 deals
- Accel1 deals
- Aglaé Ventures1 deals
- Amundi Private Equity Funds1 deals
- Anaxago1 deals
- Apollon Invest1 deals
- Asabys Partners1 deals
- Atmos Ventures1 deals
- AVANTECA Partners1 deals